Company Overview of Vactech Oy
Vactech Oy develops vaccine technologies for the prevention of human diseases. The company focuses on the vaccine development, biomarker and target discovery, and diagnostic assays for microbial infections. It develops vaccines for microbes, as well as microbe-host interactions underlying chronic human diseases. The company’s products include vaccines against picornaviruses, which infect human beings and cause common cold, carditis, hepatitis, meningitis, otitis, and paralysis; and enteroviruses that cause severe illnesses. In addition, it offers contract-type research services for defined purposes. The company was founded in 2001 and is based in Tampere, Finland.
Founded in 2001
358 3447 8111
358 9191 26675
Key Executives for Vactech Oy
Similar Private Companies By Industry
|Arctic Diagnostics Oy||Europe|
|Bioxid Ltd Oy||Europe|
|Blueprint Genetics Oy||Europe|
Recent Private Companies Transactions
June 23, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Vactech Oy, please visit www.vactech.fi. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.